Cardinal Capital Management Inc (North Carolina)’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,034
| Closed | -$992K | – | 134 |
|
|
2024
Q2 | $992K | Buy |
34,034
+2,965
| +10% | +$87.9K | 0.17% | 118 |
|
|
2024
Q1 | $1.1M | Buy |
31,069
+8,968
| +41% | +$359K | 0.18% | 120 |
|
|
2023
Q4 | $962K | Buy |
22,101
+347
| +2% | +$13.7K | 0.18% | 117 |
|
|
2023
Q3 | $831K | Buy |
21,754
+737
| +4% | +$31K | 0.17% | 119 |
|
|
2023
Q2 | $864K | Buy |
21,017
+398
| +2% | +$19.2K | 0.17% | 116 |
|
|
2023
Q1 | $1.18M | Buy |
20,619
+43
| +0.2% | +$2.42K | 0.25% | 99 |
|
|
2022
Q4 | $1.15M | Buy |
20,576
+734
| +4% | +$37.4K | 0.25% | 102 |
|
|
2022
Q3 | $841K | Buy |
19,842
+727
| +4% | +$37.2K | 0.2% | 110 |
|
|
2022
Q2 | $1.03M | Buy |
19,115
+447
| +2% | +$26.8K | 0.24% | 104 |
|
|
2022
Q1 | $1.2M | Buy |
18,668
+911
| +5% | +$60K | 0.24% | 100 |
|
|
2021
Q4 | $1.19M | Buy |
17,757
+15
| +0.1% | +$1.01K | 0.24% | 98 |
|
|
2021
Q3 | $1.22M | Buy |
17,742
+90
| +0.5% | +$6.36K | 0.26% | 96 |
|
|
2021
Q2 | $1.21M | Sell |
17,652
-52
| -0.3% | -$3.68K | 0.25% | 103 |
|
|
2021
Q1 | $1.22M | Buy |
17,704
+131
| +0.7% | +$8.88K | 0.27% | 97 |
|
|
2020
Q4 | $1.14M | Buy |
17,573
+374
| +2% | +$20.1K | 0.27% | 97 |
|
|
2020
Q3 | $812K | Buy |
17,199
+531
| +3% | +$25.3K | 0.22% | 96 |
|
|
2020
Q2 | $783K | Buy |
16,668
+956
| +6% | +$47K | 0.23% | 100 |
|
|
2020
Q1 | $701K | Sell |
15,712
-1,641
| -9% | -$86.1K | 0.23% | 101 |
|
|
2019
Q4 | $1.01M | Sell |
17,353
-347
| -2% | -$20.7K | 0.26% | 98 |
|
|
2019
Q3 | $1.06M | Sell |
17,700
-49
| -0.3% | -$2.92K | 0.29% | 89 |
|
|
2019
Q2 | $991K | Sell |
17,749
-237
| -1% | -$12.2K | 0.28% | 93 |
|
|
2019
Q1 | $1M | Buy |
17,986
+87
| +0.5% | +$4.43K | 0.29% | 92 |
|
|
2018
Q4 | $807K | Buy |
17,899
+287
| +2% | +$15.7K | 0.27% | 94 |
|
|
2018
Q3 | $1.16M | Buy |
17,612
+32
| +0.2% | +$1.99K | 0.33% | 86 |
|
|
2018
Q2 | $1.13M | Buy |
17,580
+45
| +0.3% | +$2.79K | 0.34% | 84 |
|
|
2018
Q1 | $970K | Sell |
17,535
-143
| -0.8% | -$7.5K | 0.3% | 90 |
|
|
2017
Q4 | $846K | Sell |
17,678
-182
| -1% | -$8.91K | 0.26% | 94 |
|
|
2017
Q3 | $901K | Buy |
17,860
+1,109
| +7% | +$57K | 0.28% | 94 |
|
|
2017
Q2 | $913K | Buy |
16,751
+1,679
| +11% | +$80.2K | 0.3% | 87 |
|
|
2017
Q1 | $635K | Buy |
15,072
+168
| +1% | +$7.18K | 0.23% | 92 |
|
|
2016
Q4 | $639K | Buy |
14,904
+1,618
| +12% | +$65.8K | 0.24% | 92 |
|
|
2016
Q3 | $548K | Buy |
13,286
+830
| +7% | +$34.8K | 0.21% | 92 |
|
|
2016
Q2 | $497K | Buy |
12,456
+602
| +5% | +$21.7K | 0.2% | 95 |
|
|
2016
Q1 | $399K | Buy |
11,854
+796
| +7% | +$24.8K | 0.17% | 101 |
|
|
2015
Q4 | $375K | Buy |
11,058
+392
| +4% | +$12.3K | 0.17% | 99 |
|
|
2015
Q3 | $318K | Sell |
10,666
-889
| -8% | -$27.8K | 0.15% | 101 |
|
|
2015
Q2 | $318K | Buy |
11,555
+2,031
| +21% | +$54.1K | 0.14% | 105 |
|
|
2015
Q1 | $240K | Buy |
+9,524
| New | +$225K | 0.1% | 111 |
|
Other funds holding IART
SHCM
Cardinal Capital Management Inc (North Carolina)'s IART Position: Q3 2024 in Review
Cardinal Capital Management Inc (North Carolina) sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 34,034 shares — an estimated $992K sold.
Cardinal Capital Management Inc (North Carolina) first reported a position in IART in Q1 2015 and held it in 38 quarters. The position peaked at $1.22M in Q1 2021. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.
- Cardinal Capital Management Inc (North Carolina) reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
- Cardinal Capital Management Inc (North Carolina) sold 34,034 Integra LifeSciences shares in Q3 2024, an estimated $992K.
- Cardinal Capital Management Inc (North Carolina) first reported a position in Integra LifeSciences in Q1 2015 and held it in 38 quarters.
- Cardinal Capital Management Inc (North Carolina)'s Integra LifeSciences position peaked at $1.22M in Q1 2021.
- 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.
Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q3 2024, filed 16 Oct 2024.